Press Releases

Opthea to Present at the Ophthalmology Innovation Summit in San Francisco

October 3, 2019

Read More

Opthea Receives A$14.6m R&D Tax Incentive

October 1, 2019

Read More

Opthea Presents Positive Data from OPT-302 Phase 2b Wet AMD Trial at EURETINA Congress

September 6, 2019

Read More

Opthea Presentation for EURETINA Congress

September 5, 2019

Read More

Opthea Ph2b of OPT-302 in wAMD to be Presented at EURETINA

September 4, 2019

Read More

Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302 in Wet AMD

August 6, 2019

Read More

Opthea to Host Investor Teleconference

August 5, 2019

Read More

Opthea’s Patent Application Covering OPT-302 to be Granted by European Patent Office

July 30, 2019

Read More

Opthea Provides Timing Update on OPT-302 Clinical Trials

July 22, 2019

Read More

Opthea Completes Final Patient Visit in Phase 2b Wet AMD Clinical Trial

May 15, 2019

Read More